Attorney Jonathan Hyman and Andrew Merickel were quoted in “Why Patent Cannabis? For Markets, Mostly,” which was published in Forbes. Excerpt: “Patents “generate interest in the company, and are something investors…
Knobbe Martens has been named one of 31 “Midsize Heavyweight” law firms nationwide by BTI Consulting Group, which conducted in-depth surveys with executives at more than 340 companies across 17…
Partner Craig Summers was quoted in “ITC Ends LilleBaby Probe Into Baby Carriers,” which was published in Law360. Excerpt: The U.S. International Trade Commission on Thursday affirmed a decision clearing several baby carrier makers…
Partners Philip Nelson and Tom Cowan were quoted in “Are You Protected?”, an article published in Medical Plastics News. Excerpt: “Web content editor Ian Bolland spoke to Philip Nelson and Tom Cowan…
Partner Kerry Taylor, Ph.D. was quoted in “Caterpillar Can’t Play Arthrex Card For Patent Tribunal Redo (1),” which was published in Bloomberg Law. Excerpt: “Caterpillar Paving Products Inc. failed to convince the Federal Circuit that its previous…
Partner Sheila Swaroop was quoted in “Generic Drug Decisions Stall as Virus Forces Patent Court Delays,” which was published in Bloomberg Law. Excerpt: The goal has “consistently” been to resolve the litigation within the…
Partner Philip Nelson was quoted in “Q&A: How Do You Protect Your IP?,” which was published in Medical Design Briefs. Excerpt: “How should medical device companies protect their intellectual property (IP)…
JD Supra has recognized Knobbe Martens attorneys as “top authors” for contributing popular thought-leadership pieces addressing key legal topics – a repeat honor for the firm. In the publication’s 2020…
Knobbe Martens is pleased to announce that it has obtained a significant trial defense victory for the firm’s longtime client Infantino in an International Trade Commission (ITC) Investigation over alleged…
Knobbe Martens is pleased to announce that the firm has once again been ranked as one of the top law firms in California for intellectual property, life sciences, and patent…
